Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1143 | 2824 | 23.2 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
889 | 2 | FLUOROQUINOLONES//QUINOLONES//CIPROFLOXACIN | 11411 |
1143 | 1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLEROXACIN | 2824 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | journal | 132587 | 14% | 3% | 391 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | journal | 126387 | 19% | 2% | 525 |
3 | FLEROXACIN | authKW | 72360 | 1% | 29% | 23 |
4 | AT 4140 | authKW | 54055 | 0% | 100% | 5 |
5 | TEMAFLOXACIN | authKW | 49415 | 0% | 57% | 8 |
6 | TROVAFLOXACIN | authKW | 46676 | 1% | 24% | 18 |
7 | LB20304 | authKW | 45044 | 0% | 83% | 5 |
8 | INFECTION | journal | 37986 | 4% | 3% | 115 |
9 | MICROBIOLOGY | WoSSC | 37216 | 48% | 0% | 1350 |
10 | INFECTIOUS DISEASES | WoSSC | 36487 | 34% | 0% | 959 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Microbiology | 37216 | 48% | 0% | 1350 |
2 | Infectious Diseases | 36487 | 34% | 0% | 959 |
3 | Pharmacology & Pharmacy | 27671 | 57% | 0% | 1617 |
4 | Medicine, General & Internal | 1399 | 12% | 0% | 331 |
5 | Pathology | 104 | 2% | 0% | 69 |
6 | Oncology | 80 | 5% | 0% | 142 |
7 | Toxicology | 76 | 2% | 0% | 67 |
8 | Medicine, Research & Experimental | 55 | 3% | 0% | 82 |
9 | Chemistry, Medicinal | 53 | 2% | 0% | 59 |
10 | Immunology | 22 | 3% | 0% | 95 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED DRUG ISTANCE BACTERIA | 21622 | 0% | 100% | 2 |
2 | ANALYT INORGAN PHYS CHEM | 10811 | 0% | 100% | 1 |
3 | ANESTHESIA ENS CARE | 10811 | 0% | 100% | 1 |
4 | BRONCOPNEUMOL 32A | 10811 | 0% | 100% | 1 |
5 | BUR TUBERCULOSIS REFUGEE HLTH | 10811 | 0% | 100% | 1 |
6 | CLIN DIGEST DIS SURG CLIN 1 | 10811 | 0% | 100% | 1 |
7 | CLIN SCI PHARMACKINET DYNAM METAB | 10811 | 0% | 100% | 1 |
8 | CRIT CARE SUBSECT | 10811 | 0% | 100% | 1 |
9 | FORMULAT PHARMACOKINET | 10811 | 0% | 100% | 1 |
10 | HLTH SCI EMERGENCY MED SERV | 10811 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 132587 | 14% | 3% | 391 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 126387 | 19% | 2% | 525 |
3 | INFECTION | 37986 | 4% | 3% | 115 |
4 | AMERICAN JOURNAL OF MEDICINE | 35547 | 7% | 2% | 192 |
5 | CHEMOTHERAPY | 33676 | 3% | 4% | 89 |
6 | EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 31708 | 5% | 2% | 136 |
7 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 29634 | 4% | 2% | 121 |
8 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 17667 | 2% | 3% | 55 |
9 | CHEMIOTERAPIA | 13315 | 1% | 6% | 21 |
10 | PATHOLOGIE BIOLOGIE | 11422 | 2% | 2% | 68 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FLEROXACIN | 72360 | 1% | 29% | 23 | Search FLEROXACIN | Search FLEROXACIN |
2 | AT 4140 | 54055 | 0% | 100% | 5 | Search AT+4140 | Search AT+4140 |
3 | TEMAFLOXACIN | 49415 | 0% | 57% | 8 | Search TEMAFLOXACIN | Search TEMAFLOXACIN |
4 | TROVAFLOXACIN | 46676 | 1% | 24% | 18 | Search TROVAFLOXACIN | Search TROVAFLOXACIN |
5 | LB20304 | 45044 | 0% | 83% | 5 | Search LB20304 | Search LB20304 |
6 | SPARFLOXACIN | 36090 | 1% | 13% | 25 | Search SPARFLOXACIN | Search SPARFLOXACIN |
7 | CAS 110871 86 8 | 32433 | 0% | 100% | 3 | Search CAS+110871+86+8 | Search CAS+110871+86+8 |
8 | OFLOXACIN | 29741 | 2% | 6% | 45 | Search OFLOXACIN | Search OFLOXACIN |
9 | CIPROFLOXACIN | 29618 | 3% | 3% | 80 | Search CIPROFLOXACIN | Search CIPROFLOXACIN |
10 | PEFLOXACIN | 28375 | 1% | 15% | 17 | Search PEFLOXACIN | Search PEFLOXACIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CAMPOLIRICHARDS, DM , MONK, JP , PRICE, A , BENFIELD, P , TODD, PA , WARD, A , (1988) CIPROFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE.DRUGS. VOL. 35. ISSUE 4. P. 373-447 | 216 | 68% | 218 |
2 | LEBEL, M , RAPP, RP , STEIN, GE , BARRIERE, SL , DRUSANO, GL , (1988) CIPROFLOXACIN - CHEMISTRY, MECHANISM OF ACTION, RESISTANCE, ANTIMICROBIAL SPECTRUM, PHARMACOKINETICS, CLINICAL-TRIALS, AND ADVERSE REACTIONS.PHARMACOTHERAPY. VOL. 8. ISSUE 1. P. 3-33 | 180 | 74% | 70 |
3 | PATON, JH , REEVES, DS , (1988) FLUOROQUINOLONE ANTIBIOTICS - MICROBIOLOGY, PHARMACOKINETICS AND CLINICAL USE.DRUGS. VOL. 36. ISSUE 2. P. 193-228 | 143 | 72% | 115 |
4 | VANCEBRYAN, K , GUAY, DRP , ROTSCHAFER, JC , (1990) CLINICAL PHARMACOKINETICS OF CIPROFLOXACIN.CLINICAL PHARMACOKINETICS. VOL. 19. ISSUE 6. P. 434-461 | 123 | 71% | 125 |
5 | BALFOUR, JA , TODD, PA , PETERS, DH , (1995) FLEROXACIN - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY IN VARIOUS INFECTIONS.DRUGS. VOL. 49. ISSUE 5. P. 794-850 | 110 | 61% | 14 |
6 | TODD, PA , FAULDS, D , (1991) OFLOXACIN - A REAPPRAISAL OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOLOGY AND THERAPEUTIC USE.DRUGS. VOL. 42. ISSUE 5. P. 825-876 | 138 | 52% | 51 |
7 | DOUET, C , CHARPIAT, B , PEYRAMOND, D , BRAZIER, JL , (1996) ORAL ADMINISTRATION VERSUS INJECTABLE ADMINISTRATION FOR THE FLUOROQUINOLONES. PHARMACOECONOMIC IMPACT AND BIBLIOGRAPHICAL STUDY.THERAPIE. VOL. 51. ISSUE 4. P. 464-475 | 69 | 88% | 5 |
8 | DAVIS, R , MARKHAM, A , BALFOUR, JA , (1996) CIPROFLOXACIN - AN UPDATED REVIEW OF ITS PHARMACOLOGY, THERAPEUTIC EFFICACY AND TOLERABILITY.DRUGS. VOL. 51. ISSUE 6. P. 1019-1074 | 131 | 35% | 200 |
9 | SANDERS, CC , (1992) REVIEW OF PRECLINICAL STUDIES WITH OFLOXACIN.CLINICAL INFECTIOUS DISEASES. VOL. 14. ISSUE 2. P. 526-538 | 104 | 57% | 13 |
10 | NEUMAN, M , (1988) CLINICAL PHARMACOKINETICS OF THE NEWER ANTIBACTERIAL 4-QUINOLONES.CLINICAL PHARMACOKINETICS. VOL. 14. ISSUE 2. P. 96-121 | 60 | 88% | 124 |
Classes with closest relation at Level 1 |